Year None20232022202120202019201820172016201520142012 Aug 10, 2023 CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates Aug 09, 2023 CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP) Jun 12, 2023 CalciMedica Announces Relisting on Nasdaq Jun 06, 2023 CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP) May 23, 2023 CalciMedica Expands Executive Team with New Appointments May 15, 2023 CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates Mar 20, 2023 CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement Mar 20, 2023 Graybug Announces Name and Trading Symbol Change
Aug 10, 2023 CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
Aug 09, 2023 CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
Jun 06, 2023 CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)
May 15, 2023 CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
Mar 20, 2023 CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
